factual
Personalized Vaccine Phase Two Success Was Unpredictable
Even though Moderna leaders asked whether the personalized cancer vaccine would work, Zaks could not predict success, arguing that the only way to know is to test it in the clinic, and that the phase two readout was successful and a phase three is now enrolling.
factualpending
Speaker
Tal ZaksEvidence Quote
“But until we test it in the clinic, we won't know. And we've been fortunate that that phase two actually read out with quite a successful readout last year. In fact, the phase three now is enrolling”
Created: 11/19/2026, 4:01:33 PM
Your notes
Loading notes...